WASHINGTON—A majority of U.S. states filed a lawsuit that accuses 20 drug companies of orchestrating a sweeping scheme to inflate drug prices and stifle competition for generic drugs, state prosecutors said on May 11.
Soaring drug prices from both branded and generic manufacturers have sparked outrage and investigations in the United States. The criticism has come from across the political spectrum—from President Donald Trump, a Republican, to progressive Democrats including Sen. Elizabeth Warren of Massachusetts, who is running for president.
